Skip to main content

Bayer's Roundup Lawsuit Settlements Are Nearing

Bayer's Roundup Lawsuit Settlements Are Nearing

Bayer's Roundup Lawsuit Settlements Are Nearing

Introduction

Mediator Ken Feinberg, appointed by the court last May for court-mandated settlement talks over allegations that Bayer AG’s glyphosate-based Roundup weed killer caused cancer, said in an interview on Thursday that he is positive about the settlement that will be made by Bayer over its Roundup weed killer.

Earlier, in its third-quarter report, Bayer disclosed that it was facing 42,700 claims, but as per the recent study, Mediator Ken Feinberg informed that the claims might have grown between 75,000 and 85,000 or maybe more, which will be followed by a fair settlement to be disclosed within the next month.

In December, Bayer agreed to postpone some Roundup trials as it lost three trials in California, resulting in combined damages of $191 million. Bayer is appealing the verdicts it lost and has put the upcoming trials on hold.

Bayer will face the two trials in Martinez, California, a suburb of San Francisco, and St. Louis, which will start today.

Currently, there are approximately 18,000 Roundup lawsuits across the United States. All the lawsuits are centralised before U.S. District Judge Vince Chhabria in the Northern District of California under federal multi-district litigation (MDL No. 2741; In Re: Roundup Products Liability Litigation).

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!